Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Since the FDA is the authority and determines who can sell CBD, I would suggest facts and evidence and the FDA say I have researched the subject
Sir, I have researched the issue and I probably know more about CBD than anyone in North America. I am a fan of Golden Leaf. Love the stock. However, strongly suggest that you review the FDA letter that was sent out in 2016 saying that CBD can not be sold as a dietary supplement. In addition, it does not have GRAS status. Therefore, it is illegal to sell. Just because vape shops are selling it does not make it legal.
Now, this issue will be challenged but I don't believe the challengers will beat the FDA or the pharmaceutical lobby that has billions behind it.
The challenge will be based on this:
There is an exception to sections 201(ff)(3)(B)(i) and (ii) if the substance was "marketed as" a dietary supplement or as a conventional food before the drug was approved or before the new drug investigations were authorized, as applicable. However, based on available evidence, FDA has concluded that this is not the case for THC or CBD. For more information on this provision, including an explanation of the phrase "marketed as," see Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues.
There are those that claim that it was marketed as a dietary supplement before GW Pharma filed an IND
https://www.fda.gov/newsevents/publichealthfocus/ucm421168.htm#dietary_supplements
See # 12
12. Can products that contain THC or cannabidiol (CBD) be sold as dietary supplements?
A. No. Based on available evidence, FDA has concluded that THC and CBD products are excluded from the dietary supplement definition under sections 201(ff)(3)(B)(i) and (ii) of the FD&C Act, respectively. Under those provisions, if a substance (such as THC or CBD) is an active ingredient in a drug product that has been approved under 21 U.S.C. § 355 (section 505 of the FD&C Act), or has been authorized for investigation as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, then products containing that substance are outside the definition of a dietary supplement. FDA considers a substance to be "authorized for investigation as a new drug" if it is the subject of an Investigational New Drug application (IND) that has gone into effect. Under FDA’s regulations (21 CFR 312.2), unless a clinical investigation meets the limited criteria in that regulation, an IND is required for all clinical investigations of products that are subject to section 505 of the FD&C Act.
There is an exception to sections 201(ff)(3)(B)(i) and (ii) if the substance was "marketed as" a dietary supplement or as a conventional food before the drug was approved or before the new drug investigations were authorized, as applicable. However, based on available evidence, FDA has concluded that this is not the case for THC or CBD. For more information on this provision, including an explanation of the phrase "marketed as," see Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues.
FDA is not aware of any evidence that would call into question its current conclusions that THC and CBD products are excluded from the dietary supplement definition under sections 201(ff)(3)(B)(i) and (ii) of the FD&C Act. Interested parties may present the agency with any evidence that they think has bearing on this issue. Our continuing review of information that has been submitted thus far has not called our conclusions into question.
Very interesting article.
https://seekingalpha.com/article/4201184-hydropothecary-approaching-billion-dollar-club
The better one is Supreme Cannabis
I love the fact that there is a 24 month agreement signed. Distribution channels are the key to any retail company regardless of whether it's Cannabis.
https://www.newcannabisventures.com/supreme-cannabis-secures-supply-agreement-for-the-province-of-ontario/
I had a friend that watched a stock (that he owned) go from from 40 cents to 52 dollars and was afraid to sell because he didn't want to pay the taxes. He sold at $1.75. He didn't save much.
I agree but execution is key. Aurora is executing and hundreds of millions so a little different.
Great and when they get that, how much money will they have to raise at at $10,000,000 market cap. Crazy dilution!!
Here is what I believe.
The U.S. government has a very large problem on its hands more complicated than most. You have vape shops selling CBD all over the United States and it's considered illegal to do so by the U.S. government. At the same time, you have the pharmaceutical lobby that will stick up for GW Pharma. If anyone thinks the Pharmaceutical companies are just going to let vape shops sell CBD dietary supplement when GW Pharma spent millions to get their drug approved, you are kidding yourself. At the same time, you have the access to healthcare crowd. Crazy triangle which no one really knows what will happen.
My guess is the U.S. gov't provides access to some sort of new compassionate use law. Watch!!
Brilliant approach by Namaste as depicted in this press release.
https://www.otcmarkets.com/stock/NXTTF/news/Namaste-Announces-Approval-of-NamasteMD-Android-App-and-Accelerates-Patient-Acquisition-in-Anticipation-of-Sales-License?id=201913
Also focusing on companies that are securing distribution that are in line with the Canadian provinces. Interesting press release from Beleave Inc. (BLEVF) this week. Seem to be setting up distribution channels.
Companies that are securing distribution are smart. Hydropothecary secures distribution through the Ontario Cannabis store
http://globenewswire.com/news-release/2018/08/20/1554206/0/en/HEXO-Reaches-Supply-Agreement-with-Ontario-Cannabis-Store.html
I think the issue is that they have a shoestring budget. The stock may be fairly valued but the snack bar market is highly competitive. Very hard to build a brand without a big budget. I know some of the management team were the founders of Clearly Canadian but with that and five dollars I can buy a coffee at Starbucks. Doesn't mean much. Also, don't like the fact that they are not revealing the names of their Australian distributor. Nutiva build a brand in North America. Why go to Australia when the North American market can still be penetrated?
Great press release. A few Canadian cannabis companies have aligned themselves with the Ontario Cannabis store. As the market takes off, distribution capabilities will be key.
http://globenewswire.com/news-release/2018/08/20/1554206/0/en/HEXO-Reaches-Supply-Agreement-with-Ontario-Cannabis-Store.html
They just announced 5 products. A colleague of mine recently met with Aurelio Auseche and the company has big plans going forward. He is really interested in building a real company with quality products and to become a force in the CBD market.
Also love the fact that they changed their company description which makes it more understandable to consumers.
About Relevium Technologies
Relevium is a publicly-traded company that operates in the $3.7 trillion-dollar worldwide wellness industry. Relevium is focused on the development, acquisition, marketing and sale of consumer products that are derived from cannabis and industrial hemp and other ingredients that are generally accepted as safe. The Company uses cannabinoids and ingredients that have achieved GRAS status (generally accepted as safe) to create brands that are sold via wholesale channels, retail channels and online distribution.
Relevium markets its products as dietary supplements, nutraceuticals, sports nutrition and nutri-cosmeceuticals. The Company plans on unveiling a complete line of dietary supplements for consumers derived from Cannabis Sativa and Cannabis Indica. The Company’s initial focus will be on creating a full spectrum extract rich in CBD (cannabidiol) which will be marketed and sold throughout North America. Relevium is also focused on developing a complete line of supplements, nutraceuticals, sports nutrition and nutri-cosmeceuticals. Relevium’s products and brands such as Bioganix® have achieved market penetration and now sold at some of the world’s largest retailers such as Walmart.com.
Products sold in Walmart
https://www.otcmarkets.com/stock/RLLVF/news/Relevium-Launches-5-New-Bioganix-Products?id=201536
Great article which relates to Aphria. In my opinion, there will be about 5-8 real players in the Canadian Cannabis space and Aphria will be one of them
https://windsorstar.com/cannabis-legalization/leamington-pot-grower-aphria-chosen-as-a-supplier-for-provinces-online-sales
Also some very interesting news from Beleave this week, another favorite Canadian cannabis company (BLEVF)
I love the fact that Supreme Cannabis is focused on building the management team. This should bode well as the pretenders in the cannabis space are separated from the real players. The additions are high quality people.
MEC stands at a 1/10 of a cent with low volume
Just more great publicity about Anaconda Mining
http://thechronicleherald.ca/business/1591321-anaconda-mining-proposes-93-million-project-for-guysborough-county
I will give a summary of what I believe will happen in the appeals process a bit later tonight. I think this is not at all bad and should be resolved quickly.
Very good news for GDSI today.
The motion has been granted by the judge which means that GDSI has been given permission for service. This is big news. I anticipate service being completed this year which means that we will know a lot within 6 months. Phenomenal news and I am happy for GDSI.
I agree and it is well said. The appeal should be resolved soon.
Anaconda Mining's Allan Cramm Named to International Mining's Technology Hall of Fame.
Great achievement and no surprise. Mr. Gramm has instrumental in assisting Anaconda with the Point Rousse project. CEO Dustin Angelo acknowledges the work of Mr. Cramm in the article. As I've said, Anaconda has a great management team.
http://www.thetelegram.com/business/anacondas-allan-cramm-named-to-international-minings-technology-hall-of-fame-233861/
The export market for CBD and cannabis will be a bigger opportunity for Canadian cannabis companies than the domestic opportunity. Since some companies like Valens are really focusing on the production and extraction of high quality cannabinoids, I believe the export opportunity will be very large.
It is common in the process. Jones Day is our law firm and they are completely on top of it. I have tremendous confidence in their abilities and I have as much confidence in the management team of Excelsior.
Anaconda CEO Dustin Angelo is committed to building shareholder value. He is constantly getting his story in front of investors in a very professional way.
https://www.nasdaq.com/press-release/president-ceo-and-director-of-anaconda-mining-inc-discusses-company-updates-with-everett-jolly-on-20180813-00310
I was up in Canada recently and the municipalities are expecting a shortfall of supply as there is a rush for medical and recreational cannabis going forward. October will be an interesting month for Valens as well as many Canadian cannabis companies. However, companies with low market caps will be the most attractive.
People also should look at this Q once again.
https://www.otcmarkets.com/stock/NXTTF/news/Namaste-Announces-Quarterly-Sales-of-41M-Representing-32-Quarter-Over-Quarter-Growth?id=198678
This a good post and I do agree.
Anaconda Mining receives permits to proceed with bulk sample at the Goldboro Gold Project
TORONTO, Aug. 1, 2018 /CNW/ - Anaconda Mining Inc. ("Anaconda" or the "Company") (TSX: ANX) (OTCQX: ANXGF) is pleased to announce that it has received the permits required to proceed with the extraction of the proposed 10,000-tonne underground bulk sample (the "Bulk Sample") at its 100%-owned Goldboro Gold Project ("Goldboro", or the "Project") in Nova Scotia, Canada. In connection with the Bulk Sample, Anaconda has engaged Cementation Canada Inc. ("Cementation") as the mining contractor to assist in the underground development and Bulk Sample extraction. Cementation is mobilizing to site today and will begin development work immediately. The Bulk Sample process is expected to take approximately four months with results to follow thereafter.
"The Bulk Sample is a key milestone in the development of the Goldboro Gold Project, the results of which will enable us to optimize the economics outlined in the Preliminary Economic Assessment, confirm mining and recovery methods and assess the mineral resource around the Bulk Sample. This work will move us closer to demonstrating the feasibility of building a mine at Goldboro. We are also extremely pleased to have Cementation, with its wealth of underground mining knowledge and focus on safety, as a key partner in extracting the Bulk Sample. We believe this has the potential to be a tremendous project for all stakeholders."
~ Dustin Angelo, President and CEO
The Bulk Sample will provide valuable geological, operational and processing information for design and optimization of the overall project in a feasibility study planned to start in September. Bulk Sample activities will involve site preparation, establishment of safe access underground and extraction of the Bulk Sample, which is expected to be approximately 10,000 tonnes. Extraction of the Bulk Sample will utilize the existing decline developed in the late 1980's with minimal development needed to access mineralized zones and planned mining stopes adjacent to existing workings.
Anaconda plans to hire local people and contractors to carry out security related duties, surface clearing, transportation and other ancillary activities. In total, including employees of Cementation, approximately 50 people will be working on the Bulk Sample at Goldboro.
A version of this news release will be available in French on Anaconda's website (www.anacondamining.com) in two to three business days.
ABOUT ANACONDA MINING INC.
Anaconda is a TSX-listed gold mining, development and exploration company, focused in the prospective Atlantic Canadian jurisdictions of Newfoundland and Nova Scotia The Company operates the Point Rousse Project located in the Baie Verte Mining District in Newfoundland, comprised of the Stog'er Tight Mine, the Pine Cove open pit mine, the Argyle Mineral Resource, the fully-permitted Pine Cove Mill and tailings facility, deep water port, and approximately 5,800 hectares of prospective gold-bearing property. Anaconda is also developing the Goldboro Project in Nova Scotia, a high-grade Mineral Resource, with the potential to leverage existing infrastructure at the Company's Point Rousse Project. The Company also has a pipeline of organic growth opportunities, including the Viking and Great Northern Projects on the Northern Peninsula and the Tilt Cove Property on the Baie Verte Peninsula.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking information" within the meaning of applicable Canadian and United States securities legislation. Forward-looking information includes, but is not limited to, disclosure regarding the economics and project parameters presented in the PEA, including, without limitation, IRR, all-in sustaining costs, NPV and other costs and economic information, possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action; the timing and costs of future development and exploration activities on the Company's projects; success of development and exploration activities; permitting time lines and requirements; time lines for further studies; planned exploration and development of properties and the results thereof; and planned expenditures and budgets and the execution thereof. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", or "will be taken", "occur", or "be achieved". Forward-looking information is based on the opinions and estimates of management at the date the information is made, and is based on a number of assumptions and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Anaconda to be materially different from those expressed or implied by such forward-looking information, including the risks outlined in this news release, risks associated with the exploration, development and mining such as economic factors as they effect exploration, future commodity prices, changes in foreign exchange and interest rates, actual results of current production, development and exploration activities, government regulation, political or economic developments, environmental risks, permitting timelines, capital expenditures, operating or technical difficulties in connection with development activities, employee relations, the speculative nature of gold exploration and development, including the risks of diminishing quantities of grades of resources, contests over title to properties, and changes in project parameters as plans continue to be refined as well as those risk factors discussed in Anaconda's annual information form for the year ended May 31, 2017, available on www.sedar.com. Although Anaconda has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. Anaconda does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
SOURCE Anaconda Mining Inc.
For further information: Anaconda Mining Inc., Dustin Angelo, President and CEO, (647) 260-1248, dangelo@anacondamining.com, www.AnacondaMining.com; Anaconda Mining Inc., Lynn Hammond, VP Public Relations, (709) 330-1260, Lhammond@anacondamining.com; Reseau ProMarket Inc., Dany Cenac Robert, Investor Relations, (514) 722-2276 x456, Dany.Cenac-Robert@ReseauProMarket.com
Thank you for posting. I go agree with the other poster that Goldboro can be bigger than Point Rousse
I was luckier enough to receive an invite to a town hall meeting with Excelsior CEO yesterday. It was in a webinar format. I have one message - I'm keeping my shares and glad I discovered Excelsior.
They are going to be doing better. Well managed company with significant production upside for the foreseeable future.
Valens Groworks has bottomed here. Not saying that they don't need more money. However, no aggressive money raises will be done at the current price level.
Anaconda Mining (ANXGF:OTCQB , ANX:TSX)
Pointe Rousee - producing 16,000 annual production
Goldboro - PEA 41,000 ounces annual production
Potential of 50,000 - 60,000 ounces of gold annual production by 2021
Generating positive cash flow
Reasonable market cap.
Comps to other similar gold producers demonstrates significant upside
About 16 potential acquisition projects in Eastern Canada with 43-101 resources
Management team hyper sensitive on returns to shareholders by running a tight ship focused on financials
I received some interesting information. I really believe this is going to make a run in the second half of the year. The single digit number is a sweet spot for worldwide institutional investors that want exposure in the cannabis sector.
I also just discovered Relevium which is a way to play Canadian CBD
There is a pullback in the stock price. Remains one of the lowest market cap plays in the Canadian cannabis stratosphere.
The numbers for this company are very good. I love the valuation expansion potential and the production upside. I am looking forward to them getting to 50-60K per year of production. They beat 2017 outlook so why can't they beat that.
It is the same old, same old. That is much more professional appeal written by people that seem to have a legal budget. However, I firmly believe the locals are for the copper project and not against it. It may be a short delay but just like the appeal from Ms. Rock, should be fine in the end.
If anyone has the chance to meet Dustin Angelo, you should. He's a first class CEO
Pointe Rousse 16,000 ounces annual production.
Potential of 50,000 - 60,000 annual production by 2021.
That is the catalyst!!